Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO
New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual Meeting
Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates
We take a look at 2012's municipal CEF performance, distribution cuts, mergers, and more.
An examination of 10 CEFs with the highest duration risk.